Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Depreciation and Depletion: 2017-2023

Historic Depreciation and Depletion for Solid Biosciences (SLDB) over the last 7 years, with Dec 2023 value amounting to $587,000.

  • Solid Biosciences' Depreciation and Depletion rose 8.91% to $587,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.6 million, marking a year-over-year increase of 7.18%. This contributed to the annual value of $2.6 million for FY2023, which is 7.18% up from last year.
  • Solid Biosciences' Depreciation and Depletion amounted to $587,000 in Q4 2023, which was down 0.17% from $588,000 recorded in Q3 2023.
  • In the past 5 years, Solid Biosciences' Depreciation and Depletion registered a high of $1.3 million during Q2 2020, and its lowest value of $438,000 during Q3 2022.
  • Moreover, its 3-year median value for Depreciation and Depletion was $706,000 (2022), whereas its average is $662,750.
  • Per our database at Business Quant, Solid Biosciences' Depreciation and Depletion soared by 162.56% in 2019 and then slumped by 46.18% in 2021.
  • Over the past 5 years, Solid Biosciences' Depreciation and Depletion (Quarterly) stood at $806,000 in 2019, then fell by 1.24% to $796,000 in 2020, then declined by 4.52% to $760,000 in 2021, then fell by 29.08% to $539,000 in 2022, then grew by 8.91% to $587,000 in 2023.
  • Its last three reported values are $587,000 in Q4 2023, $588,000 for Q3 2023, and $703,000 during Q2 2023.